Fractyl Health Inc [NASDAQ: GUTS] gained 32.67% on the last trading session, reaching $1.34 price per share at the time.
Fractyl Health Inc represents 49.92 million in outstanding shares, while the company has a total market value of $96.74 million with the latest information. GUTS stock price has been found in the range of $1.06 to $1.36.
If compared to the average trading volume of 878.67K shares, GUTS reached a trading volume of 74506905 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Fractyl Health Inc [GUTS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GUTS shares is $6.52 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GUTS stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Fractyl Health Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 15, 2025. While these analysts kept the previous recommendation, Ladenburg Thalmann raised their target price to Buy. The new note on the price target was released on August 28, 2025, representing the official price target for Fractyl Health Inc stock.
Trading performance analysis for GUTS stock
Fractyl Health Inc [GUTS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 35.56. With this latest performance, GUTS shares gained by 35.30% in over the last four-week period, additionally plugging by 6.35% over the last 6 months – not to mention a drop of -34.95% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GUTS stock in for the last two-week period is set at 73.38, with the RSI for the last a single of trading hit 0.0874, and the three-weeks RSI is set at 0.0921 for Fractyl Health Inc [GUTS]. The present Moving Average for the last 50 days of trading for this stock 1.2194, while it was recorded at 1.0646 for the last single week of trading, and 1.5441 for the last 200 days.
Fractyl Health Inc [GUTS]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Fractyl Health Inc [GUTS] shares currently have an operating margin of -587305.88% and a Gross Margin at -5776.47%. Fractyl Health Inc’s Net Margin is presently recorded at -586864.71%.
Fractyl Health Inc (GUTS) Capital Structure & Debt Analysis
According to recent financial data for Fractyl Health Inc. ( GUTS), the Return on Equity (ROE) stands at -379.75%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -95.73%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Fractyl Health Inc’s Return on Invested Capital (ROIC) is -259.29%, showcasing its effectiveness in deploying capital for earnings.
Fractyl Health Inc (GUTS) Efficiency & Liquidity Metrics
Fractyl Health Inc (GUTS) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Fractyl Health Inc. (GUTS) effectively leverages its workforce, generating an average of -$932429.91 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.22% and a Quick Ratio of 1.22%, indicating strong ability to cover short-term liabilities.
Fractyl Health Inc [GUTS]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Fractyl Health Inc posted -0.43/share EPS, while the average EPS was predicted by analysts to be reported at -0.5/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.07. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GUTS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Fractyl Health Inc go to 12.94%.
An analysis of Institutional ownership at Fractyl Health Inc [GUTS]
There are presently around $53.83%, or 55.69%% of GUTS stock, in the hands of institutional investors. The top three institutional holders of GUTS stocks are: DEER MANAGEMENT CO. LLC with ownership of 4.77 million shares, which is approximately 9.9603%. HCC MANAGER LLC, holding 4.67 million shares of the stock with an approximate value of $$34.59 million in GUTS stocks shares; and HCC MANAGER LLC, currently with $$18.17 million in GUTS stock with ownership which is approximately 8.8825%.
